ASPR awards $25.3M contract for biotechnology R&D to Arizona State University over 12 years

Contract Overview

Contract Amount: $25,347,509 ($25.3M)

Contractor: Arizona State University

Awarding Agency: Department of Health and Human Services

Start Date: 2009-12-18

End Date: 2022-11-16

Contract Duration: 4,716 days

Daily Burn Rate: $5.4K/day

Competition Type: FULL AND OPEN COMPETITION

Number of Offers Received: 10

Pricing Type: COST NO FEE

Sector: R&D

Official Description: TAS::75 0140::TAS

Place of Performance

Location: TEMPE, MARICOPA County, ARIZONA, 85287

State: Arizona Government Spending

Plain-Language Summary

Department of Health and Human Services obligated $25.3 million to ARIZONA STATE UNIVERSITY for work described as: TAS::75 0140::TAS Key points: 1. Significant long-term investment in biotechnology research. 2. Sole awardee suggests potential for specialized expertise or limited market. 3. Contract duration spans over a decade, indicating ongoing project needs. 4. Focus on R&D in a critical health sector.

Value Assessment

Rating: fair

The contract value of $25.3M over 12 years averages approximately $2.1M annually. Without specific deliverables or benchmarks, it's difficult to assess value. However, for specialized R&D, this annual figure may be within a reasonable range.

Cost Per Unit: N/A

Competition Analysis

Competition Level: full-and-open

The contract was awarded under full and open competition, suggesting a competitive process to select the best offeror. The definitive contract type implies a fixed scope and price, though the 'COST NO FEE' indicates cost reimbursement.

Taxpayer Impact: Taxpayer funds are supporting advanced biotechnology research, which could lead to future public health benefits. The long duration and cost reimbursement structure warrant oversight to ensure efficient use of funds.

Public Impact

Supports advancements in biotechnology with potential public health applications. Long-term commitment to a single research institution. Funding for research and development in a critical scientific field.

Waste & Efficiency Indicators

Waste Risk Score: 50 / 10

Warning Flags

Positive Signals

Sector Analysis

This contract falls within the Research and Development in Biotechnology sector. Spending in this area is crucial for innovation in healthcare and life sciences. Benchmarks for R&D contracts vary widely based on scope and duration.

Small Business Impact

The data does not indicate any specific set-asides or participation goals for small businesses in this contract. The award to a large university suggests it was not primarily targeted towards small business development.

Oversight & Accountability

The long duration of the contract necessitates robust oversight from the Office of Assistant Secretary for Preparedness and Response to ensure milestones are met and funds are used effectively. Regular reviews of research progress and expenditures are critical.

Related Government Programs

Risk Flags

Tags

research-and-development-in-biotechnolog, department-of-health-and-human-services, az, definitive-contract, 10m-plus

Frequently Asked Questions

What is this federal contract paying for?

Department of Health and Human Services awarded $25.3 million to ARIZONA STATE UNIVERSITY. TAS::75 0140::TAS

Who is the contractor on this award?

The obligated recipient is ARIZONA STATE UNIVERSITY.

Which agency awarded this contract?

Awarding agency: Department of Health and Human Services (Office of Assistant Secretary for Preparedness and Response).

What is the total obligated amount?

The obligated amount is $25.3 million.

What is the period of performance?

Start: 2009-12-18. End: 2022-11-16.

What specific research objectives and expected outcomes are associated with this $25.3M contract, and how are they being measured to ensure value for taxpayer investment?

The contract details are limited, but it's crucial to understand the specific research objectives and expected outcomes. Measuring value requires clearly defined milestones, deliverables, and performance metrics. Without these, assessing the return on the $25.3M investment is challenging. Regular progress reports and independent evaluations would be necessary to ensure accountability and track scientific advancements against the funding provided.

Given the 'COST NO FEE' structure and long duration, what mechanisms are in place to mitigate the risk of cost overruns and ensure efficient use of funds?

Cost-reimbursement contracts, especially those spanning over a decade, inherently carry a risk of cost overruns. Mitigation strategies should include stringent financial controls, regular audits, and detailed budget reviews. The 'NO FEE' aspect suggests the contractor is not profiting beyond cost recovery, but oversight is still needed to prevent unnecessary expenses. Clear guidelines on allowable costs and performance-based payment adjustments can further enhance efficiency.

How does the biotechnology research funded by this contract align with current public health priorities and preparedness goals of the HHS?

The alignment of this contract with public health priorities is critical for justifying the significant taxpayer investment. Research and Development in Biotechnology can directly address emerging health threats, vaccine development, or novel therapeutic strategies. The Office of the Assistant Secretary for Preparedness and Response (ASPR) typically focuses on such areas. Understanding the specific research focus and its potential impact on national health security would clarify its strategic importance.

Industry Classification

NAICS: Professional, Scientific, and Technical ServicesScientific Research and Development ServicesResearch and Development in Biotechnology

Product/Service Code: RESEARCH AND DEVELOPMENTN – Health R&D Services

Competition & Pricing

Extent Competed: FULL AND OPEN COMPETITION

Solicitation Procedures: NEGOTIATED PROPOSAL/QUOTE

Offers Received: 10

Pricing Type: COST NO FEE (S)

Evaluated Preference: NONE

Contractor Details

Address: 1711 S RURAL RD ADM B 160, TEMPE, AZ, 85287

Business Categories: Category Business, Educational Institution, Government, Higher Education, U.S. National Government, Not Designated a Small Business, Higher Education (Public), U.S. Regional/State Government, Special Designations, U.S.-Owned Business

Financial Breakdown

Contract Ceiling: $52,062,643

Exercised Options: $34,685,397

Current Obligation: $25,347,509

Contract Characteristics

Commercial Item: COMMERCIAL PRODUCTS/SERVICES PROCEDURES NOT USED

Cost or Pricing Data: YES

Timeline

Start Date: 2009-12-18

Current End Date: 2022-11-16

Potential End Date: 2022-11-16 00:00:00

Last Modified: 2022-11-16

More Contracts from Arizona State University

View all Arizona State University federal contracts →

Other Department of Health and Human Services Contracts

View all Department of Health and Human Services contracts →

Explore Related Government Spending